Oncostatin M–induced growth inhibition and morphological changes of MDA-MB231 breast cancer cells are abolished by blocking the MEK/ERK signaling pathway

By Li C.   Ahlborn T.E.   Kraemer F.B.   Liu J.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 2, 2001-03 ,pp. : 111-121

Springer Publishing Company

Access to resources Recommend Favorite

Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells

By Korah Reju   Choi Lydia   Barrios Judith   Wieder Robert  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 319-322

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of NF-B Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells

By Shibata A.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 3, 2002-06 ,pp. : 237-243

Springer Publishing Company

Access to resources Recommend Favorite

Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E₂ (PGE₂) output

By Miller M.E.   Holloway A.C.   Foster W.G.  

Clinical and Experimental Metastasis, Vol. 22, Iss. 2, 2005-04 ,pp. : 149-156

Springer Publishing Company

Access to resources Recommend Favorite

Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65

By            

Molecular Medicine Reports, Vol. 5, Iss. 4, 2012-01 ,pp. : 1019-1022

Spandidos Publications

Access to resources Recommend Favorite